About Index Trending news
Analyze
Pricing
CRISPR Therapeutics

CRISPR Therapeutics

Work at CRISPR Therapeutics? Add yourself to this profile

CRISPR Therapeutics

Elsewhere

Alexa global traffic share

Latest funding Show all
IPO
$56,000,000
Venture capital (Series B)
$38,000,000
New Leaf Venture Partners, Franklin Templeton Investments, Wellington Capital Management, +1
Employees

Team size

10+
Locations
HQ
$56,000,000 IPO
Xconomy

CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals' Haul

Science Health
$38,000,000 Venture capital (Series B)
FierceBiotech , businesswire

CRISPR Therapeutics adds $38M to Series B pot, but lags behind Parker

Funding Science Health
$64,000,000 Venture capital (Series B)
Added by
via FierceBiotech

As patent battle brews, Celgene and GSK lead $64M raise for CRISPR Therapeutics

Science
Xconomy

Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture

Health Science